Why Danaher Stock Crashed in February
Shares in life sciences and diagnostics focused company Danaher Corporation (NYSE: DHR) slumped 10.1% in February according to data provided by S&P Global Market Intelligence. There's no point ignoring the elephant in the room. The stock's down move in February is correlated with the general market sell-off due to fears around the impact on global growth from the COVID-19 outbreak.
Image source: Getty Images.
It may seem puzzling that the market should be so keen to sell off a healthcare stock that would likely see increased spending due to the high-profile spread of a disease, but in the short-term, markets are anything but rational.
Source Fool.com
